Irx Therapeutics

Permanently closed
140 W 57th St Ste 3D
New York, NY 10019

Ernexa Therapeutics is a pioneering company focused on developing innovative cell therapies aimed at treating advanced cancer and autoimmune diseases. Their core technology centers around engineering induced pluripotent stem cells (iPSCs) into mesenchymal stem cells (iMSCs) that can effectively target tumors and inflammation.

The company's lead product, ERNA-101, offers new hope for ovarian cancer patients by enhancing the immune system's ability to recognize and attack cancer cells, while ERNA-201 provides a promising treatment avenue for autoimmune diseases by precisely targeting inflammation. Both therapies are designed to deliver scalable off-the-shelf treatment solutions without needing patient-specific cell harvesting.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesNew YorkNew YorkIrx Therapeutics